Analysts/Institutional Investor Meet/Con. Call Updates Natural Capsules Limited has informed the Exchange about Transcript Natural Capsules Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates Natural Capsules Limited has informed the Exchange about Transcript Natural Capsules Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates Natural Capsules Limited has informed the Exchange about Transcript Natural Capsules Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates Natural Capsules Limited has informed the Exchange about Transcript Natural Capsules Limited has informed the Exchange about Transcript
Company Update Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026. Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026.
Company Update Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026. Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026.
Company Update Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026. Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026.
Company Update Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026. Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026.
Company Update This has reference to our intimation under regulation 30(9) of SEBI (LODR) Regulation, 2015 submitted to the Stock Exchange on May 27, 2026, regarding the outcome of the Board Meeting of Material Unlisted Subsidiary (i.e. Natural Biogenex Private Limited) dealing the approval of the Right Issue. We wish to inform the exchange that due to a Typographical /Clerical error, the total number of Equity Shares for the right issue was in inadvertently mentioned as 11,11,200 instead of
Investor Presentation Natural Capsules Limited has informed the Exchange about Investor Presentation Natural Capsules Limited has informed the Exchange about Investor Presentation
Investor Presentation Natural Capsules Limited has informed the Exchange about Investor Presentation Natural Capsules Limited has informed the Exchange about Investor Presentation
Investor Presentation Natural Capsules Limited has informed the Exchange about Investor Presentation Natural Capsules Limited has informed the Exchange about Investor Presentation
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.